Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma

By Santoni Matteo  

Journal of Neuro-Oncology, Vol. 113, Iss. 3, 2013-07 ,pp. : 397-401

Springer Publishing Company

Access to resources Recommend Favorite

Benefit of tumor resection for recurrent glioblastoma

By Quick Johanna   Gessler Florian   Dützmann Stephan   Hattingen Elke   Harter Patrick   Weise Lutz   Franz Kea   Seifert Volker   Senft Christian  

Journal of Neuro-Oncology, Vol. 117, Iss. 2, 2014-04 ,pp. : 365-372

Springer Publishing Company

Access to resources Recommend Favorite

Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression

By McNamara Mairéad   Lwin Zarnie   Jiang Haiyan   Templeton Arnoud   Zadeh Gelareh   Bernstein Mark   Chung Caroline   Millar Barbara-Ann   Laperriere Normand   Mason Warren  

Journal of Neuro-Oncology, Vol. 117, Iss. 1, 2014-03 ,pp. : 147-152

Springer Publishing Company

Access to resources Recommend Favorite

Continuous low-dose temozolomide and celecoxib in recurrent glioblastoma

By Stockhammer Florian   Misch Martin   Koch Arend   Czabanka Marcus   Plotkin Michail   Blechschmidt Cristiane   Tuettenberg Jochen   Vajkoczy Peter  

Journal of Neuro-Oncology, Vol. 100, Iss. 3, 2010-12 ,pp. : 407-415

Springer Publishing Company

Access to resources Recommend Favorite

Recurrent spinal cord glioblastoma: salvage therapy with bevacizumab

By Chamberlain Marc   Johnston Sandra  

Journal of Neuro-Oncology, Vol. 102, Iss. 3, 2011-05 ,pp. : 427-432

Springer Publishing Company

Access to resources Recommend Favorite